Coronavirus

 
Vaccine Policy Shifts, Public Trust, and Countering Misinformation
August 18, 2025

Infectious disease expert Amesh Adalja, MD, discusses new vaccine policies, misinformation, and how PCPs can build confidence during National Immunization Awareness Month.

Preparing for the 2025-26 Respiratory Virus Season: A Q&A With Sarah Sams, MD
August 18, 2025

Family physician Sarah Sams, MD, shares practical strategies on vaccine updates, coadministration, and addressing hesitancy this respiratory season.

COVID-19 Infection Raises Risk of Asthma and Other Respiratory Type-2 Inflammatory Diseases
August 15, 2025

Large US cohort study finds COVID-19 infection increases short-term risk of asthma, allergic rhinitis, and chronic rhinosinusitis, while vaccination lowers these risks.

Combating Vaccine Misinformation: Q&A With Amesh Adalja, MD
August 14, 2025

Infectious disease expert Amesh Adalja, MD, discusses key vaccine policy changes, strategies to combat misinformation, and ways PCPs can boost vaccine confidence.

KFF COVID-19 Vaccine Survey: Policy Shifts, Trust Gaps, and Vaccine Intentions
August 14, 2025

A recent poll reveals most US adults are hesitant about fall COVID-19 vaccinations, highlighting confusion over federal policies and declining trust in health agencies.

Back-to-School Vaccine Catch-Up: Strategies From a Family Physician
August 11, 2025

From EMR reports to targeted nurse visits, Sarah Sams, MD, outlines practical ways PCPs can catch up pediatric vaccinations before school starts.

11 US Vaccine Policy Updates: How Will They Affect Your Practice?
August 06, 2025

Since his Senate approval as head of HHS in February, RFK Jr has enacted and/or proposed seismic changes to US vaccine policy that will impact your daily care of patients.

Amesh Adalja, MD, on How to Defuse Vaccine Safety Concerns Without Derailing the Visit
July 31, 2025

Dr Adalja offers evidence-based strategies to address patient concerns about aluminum and thimerosal in vaccines.

Amesh Adalja, MD, Breaks Down 2025 Vaccine Policy Shifts for Primary Care
July 30, 2025

Infectious disease expert Amesh Adalja, MD, outlines the biggest vaccine policy shifts of 2025, including changes to COVID-19 and flu vaccine recommendations.

FDA Grants Full Approval of Moderna’s COVID-19 Vaccine for High-Risk Children Aged 6 Months to 11 Years
July 10, 2025

Moderna’s Spikevax receives full FDA approval for use in children at increased risk for COVID-19, expanding protection ahead of the 2025–2026 virus season.